
Co-Diagnostics CODX
$ 0.24
0.0%
Quarterly report 2025-Q3
added 11-13-2025
Country |
|
IPO year |
2017 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
29.3 M |
Market Cap[1] |
$ 7.04 M |
EBITDA (LTM) |
$ -32.7 M |
P/E (LTM) |
-0.24 |
P/S (LTM) |
6.75 |
EPS (LTM) |
-0.95 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Brainsway Ltd.
BWAY
|
$ 19.37 | - | $ 99.4 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 21.18 | - | $ 228 M | Nasdaq Global Market | ||
|
Castle Biosciences
CSTL
|
$ 39.4 | - | $ 1.09 B | Nasdaq Global Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Danaher Corporation
DHR
|
$ 230.32 | - | $ 168 B | NYSE,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 10.04 | - | $ 285 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.52 | - | $ 1.93 M | Nasdaq Capital Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.57 | - | $ 18.8 B | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DexCom
DXCM
|
$ 67.57 | - | $ 26.1 B | Nasdaq Global Select Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Fulgent Genetics
FLGT
|
$ 26.72 | - | $ 808 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.48 | - | $ 1.05 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 102.25 | - | $ 4.03 B | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Anixa Biosciences
ANIX
|
$ 3.2 | - | $ 102 K | Nasdaq Capital Market | ||
|
Myriad Genetics
MYGN
|
$ 6.48 | - | $ 587 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 5.08 | - | $ 2.73 M | Nasdaq Global Select Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Neogen Corporation
NEOG
|
$ 7.13 | - | $ 1.55 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 226.92 | - | $ 41.1 B | NYSE,SPB | ||
|
National Research Corporation
NRC
|
$ 18.66 | - | $ 458 M | Nasdaq Global Select Market | ||
|
Guardant Health
GH
|
$ 102.98 | - | $ 12.6 B | Nasdaq Global Select Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Personalis
PSNL
|
$ 8.14 | - | $ 482 M | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 29.3 | - | $ 1.23 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
$ 45.37 | - | $ 10.1 B | NYSE | ||
|
RadNet
RDNT
|
$ 73.15 | - | $ 5.34 B | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 134.95 | - | $ 21.5 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 203.66 | - | $ 10.5 B | NYSE,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 175.94 | - | $ 19.5 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 6.82 | - | $ 884 M | Nasdaq Global Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 253.89 | - | $ 21.3 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 580.74 | - | $ 222 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 182.84 | - | $ 15.1 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 688.48 | - | $ 56.8 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 66.71 | - | $ 4.62 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 420.1 | - | $ 30.1 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.